Mental Health Daily

Cognitive Function Does Not Predict Response to tDCS for Depression (2023 Trial)

by GLOOM

Transcranial Direct Current Stimulation (tDCS) has been explored as a potential treatment for major depressive disorder (MDD), particularly for patients who have not responded to traditional treatments like selective serotonin reuptake inhibitors (SSRIs). This non-invasive technique involves applying a weak electrical current to the prefrontal cortex of the brain, aiming to modulate neurocognitive functions. However, …

Tramadol for Depression: Highly Effective as Off-Label Antidepressant (According to User Reviews)

by GLOOM

Tramadol, commonly known for its pain-relieving properties, has emerged as an effective off-label treatment for depression according to patient experiences and reviews. A recent analysis of tramadol’s antidepressant potential examined user feedback – comparing its efficacy and safety with established antidepressants. It considered the perspectives of patients who have found relief from depression with tramadol, …

Are Mystical Experiences Required for the Antidepressant Effects of Ketamine & Psychedelics?

by GLOOM

The intersection of mental health treatment and pharmacology is witnessing a remarkable shift with the growing interest in ketamine and classic psychedelics like psilocybin for their rapid and sustained antidepressant effects. Unlike traditional antidepressants, these substances offer hope for those with treatment-resistant depression by potentially transforming treatment paradigms. However, it remains somewhat unclear as to …

Tianeptine Trends in the U.S.: Antidepressant, Nootropic, Street Drug (“Gas Station Heroin” & ZaZa)

by GLOOM

Tianeptine is an atypical antidepressant that has been approved in several countries for treating depression but is not authorized for medical use in the United States. Despite this, it has found a significant market in the U.S. as a nootropic, often sold under names like ZaZa or Tianna Red, and has been nicknamed “gas station …

Ketamine Increases Amygdala Volume in Treatment-Resistant Depression (TRD) (2024 MRI Study)

by GLOOM

Depression is a complex mental health condition that significantly affects an individual’s emotional and physical well-being. Recent advances in neuroimaging have provided deeper insights into how major depressive disorder (MDD) alters brain structures, particularly the hippocampus and amygdala, and how treatments like ketamine can potentially reverse these changes. A new study using 3T and 7T …

Nortriptyline-Induced “Room Tilt Illusion”: A Rare Adverse Event of Antidepressants (2024 Case Report)

by GLOOM

Room Tilt Illusion (RTI) presents a perplexing challenge to both patients and physicians, transforming the familiar into the surreal as surroundings appear rotated or flipped. This rare condition, often linked to neurological or vestibular disorders, has recently been observed as an adverse effect of the antidepressant nortriptyline, used in treatment-resistant depression. A case report highlights …

Effects of Stress & Negative Life Events on Brain Structure Connectivity in Adolescents (2024 Study)

by GLOOM

Adolescence marks a pivotal era of transformation, where the brain undergoes significant development, shaping the trajectory of an individual’s emotional and psychological maturity. Recent studies, including one leveraging data from the IMAGEN Consortium, have evaluated how negative life events during these formative years can subtly yet significantly alter the structural connectivity of the adolescent brain. …